Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
46.98
+1.49 (3.28%)
At close: Aug 10, 2026, 4:00 PM EDT
47.30
+0.32 (0.68%)
After-hours: Aug 10, 2026, 4:18 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $2.25 billion as of August 10, 2026. Its market cap has increased by 324.45% in one year.
Market Cap
2.25B
Enterprise Value
1.83B
1-Year Change
324.45%
Ranking
Category
Stock Price
$46.98
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $2.25B, an increase of 274.80%. That is a compound annual growth rate of 83.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.25B | 55.88% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sionna Therapeutics | 2.31B |
| UroGen Pharma | 2.30B |
| Palvella Therapeutics | 2.27B |
| Harmony Biosciences Holdings | 2.24B |
| ADMA Biologics | 2.22B |
| Biohaven | 2.21B |
| AbCellera Biologics | 2.12B |
| Stoke Therapeutics | 2.11B |